PROLM25 Antibody

What is PROLM25 Antibody and what is its primary target?

PROLM25 Antibody belongs to the family of antibodies targeting progranulin proteins, which are secreted proteins that act as key regulators of lysosomal function and growth factors involved in inflammation, wound healing, and cell proliferation . This antibody is designed for research applications involving human protein targets and can be utilized in various experimental contexts. Like other progranulin-targeting antibodies, PROLM25 recognizes specific epitopes within the propeptide domain region of the protein .

What experimental applications is PROLM25 Antibody validated for?

The PROLM25 Antibody has been validated for several research applications, including:

• Enzyme-linked immunosorbent assays (ELISA)

• Western blotting/immunoblotting

• Immunoprecipitation (IP)

• Immunofluorescence (IF) techniques

• Potential applications in flow cytometry and multiplex imaging

When selecting this antibody for your research, verify the specific validation data for your intended application, as performance can vary between experimental contexts.

How should PROLM25 Antibody be stored and handled to maintain optimal activity?

For optimal preservation of antibody activity:

• Store at -20°C for long-term storage

• Avoid repeated freeze-thaw cycles by aliquoting upon receipt

• Keep working solutions at 4°C for short-term use (typically 1-2 weeks)

• Protect from light if the antibody is conjugated to a fluorophore

• Follow manufacturer recommendations for specific formulations, as carrier-free preparations may have different stability profiles than those containing BSA or other stabilizers

How can I find validation data for PROLM25 Antibody across different experimental systems?

To locate comprehensive validation data:

• Search specialized antibody data repositories that share validation and experimental results

• Utilize antibody search engines to compare available data across vendors

• Review target-specific repositories for information on progranulin antibodies

• Check application-specific repositories (e.g., imaging repositories for IF/IHC applications)

• Examine validation data in repositories specific to relevant disease models

These resources provide critical information to help determine if the antibody is suitable for your specific experimental system and conditions.

What controls should be included when using PROLM25 Antibody in protein detection experiments?

A methodologically sound experimental design should include:

• Positive controls:

  • Known samples expressing the target protein

  • Recombinant target protein at known concentrations

• Negative controls:

  • Samples with target protein knockdown/knockout

  • Isotype-matched irrelevant antibodies

  • Secondary antibody-only controls

• Specificity controls:

  • Pre-adsorption with blocking peptides

  • Parallel testing with alternative antibodies targeting different epitopes of the same protein

These controls help validate results and troubleshoot potential issues with antibody specificity or experimental conditions.

How should PROLM25 Antibody concentration be optimized for different experimental applications?

Optimization strategy should follow a systematic approach:

• Begin with manufacturer-recommended dilutions as a starting point

• Perform titration experiments using 2-3 fold serial dilutions

• For immunoblotting: Test 1:500 to 1:5000 dilutions

• For immunofluorescence: Begin with 1:100 to 1:1000 dilutions

• For ELISA: Create a standard curve using 1:100 to 1:10,000 dilutions

Evaluate signal-to-noise ratio at each concentration to determine optimal working dilution for your specific sample type and experimental conditions. Document optimization procedures thoroughly to ensure reproducibility across experiments .

What sample preparation methods are recommended when using PROLM25 Antibody?

Sample preparation should be tailored to both the antibody requirements and experimental application:

For cell/tissue lysates:

• Use lysis buffers containing appropriate protease inhibitors

• Determine if denaturing or non-denaturing conditions are optimal

• Adjust protein concentration to 0.5-2 mg/ml for most applications

For immunohistochemistry/immunofluorescence:

• Test multiple fixation methods (paraformaldehyde, methanol, acetone)

• Optimize antigen retrieval methods (heat-induced vs. enzymatic)

• Determine optimal blocking solutions to minimize background

For flow cytometry:

• Evaluate cell permeabilization requirements if the epitope is intracellular

• Test different fixation protocols to preserve epitope recognition

How can I assess potential cross-reactivity of PROLM25 Antibody with related protein isoforms?

To systematically evaluate antibody specificity against related isoforms:

• Perform immunoblotting against recombinant proteins of all known isoforms

• Test samples from knockdown/knockout models for residual signal

• Conduct epitope mapping to identify specific binding regions

• Employ mass spectrometry to identify all proteins captured in immunoprecipitation

• Compare reactivity patterns with other antibodies targeting the same protein through different epitopes

This comprehensive approach helps identify potential cross-reactivity issues that could confound experimental results .

What strategies can mitigate the risk of epitope masking when using PROLM25 Antibody in complex biological samples?

To address epitope masking challenges:

• Sample preparation modifications:

  • Test multiple extraction buffers with varying detergent compositions

  • Optimize denaturation conditions (temperature, reducing agents)

  • Evaluate different antigen retrieval methods for fixed samples

• Experimental approaches:

  • Consider using antibody combinations targeting different epitopes

  • Test both native and denaturing conditions in parallel

  • Employ epitope unmasking techniques specific to your sample type

• Analytical considerations:

  • Compare results across multiple detection methods

  • Verify findings with orthogonal techniques that don't rely on antibody recognition

How does PROLM25 Antibody performance compare across different species samples?

When evaluating cross-species reactivity:

• Verify sequence homology of the target epitope across species of interest

• Perform side-by-side validation using positive control samples from each species

• Adjust experimental conditions (buffer composition, incubation time/temperature) for optimal performance with each species

• Consider epitope conservation analysis to predict potential cross-reactivity

• Document species-specific optimization parameters to ensure reproducibility

If working with non-validated species, additional validation steps should be performed before proceeding with full experiments .

What approaches can identify and mitigate potential antibody-induced artifacts in imaging experiments?

To address potential artifacts in imaging applications:

• Experimental design considerations:

  • Include fluorophore-only controls to assess background fluorescence

  • Test multiple fixation and permeabilization methods

  • Compare staining patterns between living and fixed cells when possible

• Advanced validation approaches:

  • Perform super-resolution microscopy to confirm subcellular localization

  • Use complementary techniques like proximity ligation assays

  • Conduct antibody competition assays with unlabeled antibody

• Image analysis strategies:

  • Apply appropriate background subtraction methods

  • Quantify signal-to-noise ratios systematically

  • Use computational approaches to distinguish specific from non-specific signals

How can batch-to-batch variability in PROLM25 Antibody be assessed and managed?

To address potential variability between antibody lots:

• Proactive assessment:

  • Request certificate of analysis with lot-specific validation data

  • Perform side-by-side testing of old and new lots on identical samples

  • Quantify differences in sensitivity and specificity between lots

• Management strategies:

  • Maintain detailed records of lot numbers used for each experiment

  • Purchase larger quantities of a single lot for long-term studies

  • Develop standardized validation protocols for testing new lots

• Experimental adjustments:

  • Re-optimize working dilutions for each new lot

  • Include standard control samples across experiments with different lots

  • Document any lot-specific modifications to protocols

What analytical approaches help resolve contradictory results when using PROLM25 Antibody across different experimental platforms?

When facing contradictory results:

• Systematic troubleshooting:

  • Verify antibody specificity using knockout/knockdown controls

  • Compare results with alternative antibodies targeting the same protein

  • Evaluate potential interference from buffer components or blocking agents

• Technical considerations:

  • Assess if differences relate to native vs. denatured protein detection

  • Examine epitope accessibility across different sample preparations

  • Consider post-translational modifications that might affect epitope recognition

• Integrative analysis:

  • Use orthogonal, antibody-independent methods to validate findings

  • Apply computational approaches to reconcile divergent datasets

  • Consult antibody data repositories for similar reported discrepancies

How can PROLM25 Antibody be validated for use in multiplexed detection systems?

For multiplexed experimental validation:

• Compatibility assessment:

  • Test for spectral overlap if using fluorescent conjugates

  • Evaluate antibody performance in multiplexing buffers

  • Assess potential cross-reactivity with other antibodies in the panel

• Optimization strategies:

  • Determine optimal antibody concentration for balanced signal across targets

  • Establish appropriate sequential staining protocols if needed

  • Validate signal specificity with appropriate single-stain controls

• Analysis considerations:

  • Apply appropriate compensation/unmixing algorithms for fluorescent detection

  • Validate multiplexed results against single-target experiments

  • Use computational methods to quantify potential signal interference

How can PROLM25 Antibody be effectively incorporated into single-cell analysis workflows?

For integration into single-cell technologies:

• Sample preparation considerations:

  • Optimize fixation protocols compatible with single-cell techniques

  • Evaluate potential impact of dissociation methods on epitope integrity

  • Develop protocols minimizing non-specific binding in low-input samples

• Technology-specific adaptations:

  • For flow cytometry/mass cytometry: Optimize staining conditions for suspension cells

  • For imaging mass cytometry: Validate metal-conjugated antibody performance

  • For single-cell protein analysis: Test compatibility with microfluidic systems

• Data analysis approaches:

  • Develop gating strategies for rare cell populations

  • Apply computational methods for handling signal dropout

  • Integrate antibody-based detection with other single-cell data types

What considerations are important when using PROLM25 Antibody in combination with other antibodies to prevent resistance development in therapeutic applications?

Lessons from therapeutic antibody combinations applicable to research contexts:

• Epitope mapping considerations:

  • Select antibodies targeting non-overlapping epitopes

  • Verify simultaneous binding capability through competition assays

  • Evaluate potential cooperative binding effects

• Resistance mitigation strategies:

  • Use antibody combinations targeting different domains/epitopes

  • Consider triple antibody combinations for enhanced coverage

  • Monitor for emergence of escape variants during longitudinal studies

• Experimental design approaches:

  • Test individual antibodies and combinations in parallel

  • Evaluate synergistic effects through dose-response matrices

  • Implement sequential vs. simultaneous treatment protocols

How can computational approaches enhance the interpretation of PROLM25 Antibody experimental data?

Advanced computational methods for antibody data analysis:

• Machine learning applications:

  • Apply image analysis algorithms for automated quantification

  • Develop predictive models for antibody binding affinity

  • Use clustering approaches to identify patterns in complex datasets

• Bioinformatic integration:

  • Map epitopes to protein structural models

  • Predict potential cross-reactivity based on sequence homology

  • Integrate antibody-based data with other -omics datasets

• Quantitative analysis:

  • Implement standardized metrics for signal-to-noise ratio assessment

  • Develop computational pipelines for batch correction across experiments

  • Apply statistical approaches appropriate for antibody-based data distributions